Developing story — details emerging. Check the source link for the latest updates.
Source: [Investing.com](https://www.investing.com/news/analyst-ratings/ubs-lowers-amgen-stock-price-target-to-430-on-drug-trial-concerns-93CH-4905802)
📰 Read Full Story
This is an aggregated headline summary. For the complete report, visit the original publisher.
Continue Reading at Investing.com ↗